156 related articles for article (PubMed ID: 30451800)
21. Synchronous Insulinoma and Glucagonoma: A Review of the Literature.
Damaskos C; Dimitroulis D; Garmpi A; Antoniou EA; Kouraklis G; Psilopatis I; Mavri M; Diamantis E; Marinos G; Kyriakos G; Farmaki P; Patsouras A; Kontzoglou K; Garmpis N
In Vivo; 2023; 37(6):2402-2408. PubMed ID: 37905620
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic neuroendocrine tumors.
Batcher E; Madaj P; Gianoukakis AG
Endocr Res; 2011; 36(1):35-43. PubMed ID: 21226566
[TBL] [Abstract][Full Text] [Related]
23. Insulinoma with low circulating insulin levels: the diagnostic value of proinsulin measurements.
Alsever RN; Roberts JP; Gerber JG; Mako ME; Rubenstein AH
Ann Intern Med; 1975 Mar; 82(3):347-50. PubMed ID: 163611
[TBL] [Abstract][Full Text] [Related]
24. Elevated pancreatic polypeptide levels in pancreatic neuroendocrine tumors and diabetes mellitus: causation or association?
Maxwell JE; O'Dorisio TM; Bellizzi AM; Howe JR
Pancreas; 2014 May; 43(4):651-6. PubMed ID: 24713673
[TBL] [Abstract][Full Text] [Related]
25. Are biochemical markers of neuroendocrine tumors coreleased with insulin following local calcium stimulation in patients with insulinomas?
Wiesli P; Uthoff H; Perren A; Pfammatter T; Zwimpfer C; Seiler H; Kindhauser R; Spinas GA; Schmid C
Pancreas; 2011 Oct; 40(7):995-9. PubMed ID: 21705951
[TBL] [Abstract][Full Text] [Related]
26. [46-year-old man with hypoglycemia after seizure. Insulinoma].
Vardarli I; Fenske A; Nauck MA; Jäckel E; Leitolf H
Dtsch Med Wochenschr; 2010 May; 135(18):913-4. PubMed ID: 20425676
[No Abstract] [Full Text] [Related]
27. Proinsulin levels and insulinomas.
Service FJ
Diabetes Care; 1989 Oct; 12(9):661-3. PubMed ID: 2551615
[No Abstract] [Full Text] [Related]
28. The role of proinsulin and insulin in the diagnosis of insulinoma: a critical evaluation of the Endocrine Society clinical practice guideline.
Guettier JM; Lungu A; Goodling A; Cochran C; Gorden P
J Clin Endocrinol Metab; 2013 Dec; 98(12):4752-8. PubMed ID: 24081736
[TBL] [Abstract][Full Text] [Related]
29. Update on insulinomas or the case of the missing (pro)insulinoma.
Cohen RM; Camus F
Diabetes Care; 1988 Jun; 11(6):506-8. PubMed ID: 2841080
[No Abstract] [Full Text] [Related]
30. PROINSULIN-PREDOMINANT PANCREATIC NEUROENDOCRINE TUMOR-INDUCED HYPOGLYCEMIA AFTER ROUX-EN-Y GASTRIC BYPASS SURGERY.
Edwards K; de La Portilla L; Mirza FS; Luthra P
AACE Clin Case Rep; 2019; 5(6):e339-e343. PubMed ID: 31967066
[TBL] [Abstract][Full Text] [Related]
31. Combined use of calcium infusion localization and a minimally invasive surgical procedure in the management of insulinoma.
Reynolds LR; Park AE; Miller RE; Karounos DG
Endocr Pract; 2002; 8(5):329-34. PubMed ID: 15251834
[TBL] [Abstract][Full Text] [Related]
32. The Pancreas as a Site of Metastasis or Second Primary in Patients with Small Bowel Neuroendocrine Tumors.
Scott AT; Pelletier D; Maxwell JE; Sherman SK; Keck KJ; Li G; Dillon JS; O'Dorisio TM; Bellizzi AM; Howe JR
Ann Surg Oncol; 2019 Aug; 26(8):2525-2532. PubMed ID: 31011904
[TBL] [Abstract][Full Text] [Related]
33. Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients.
Qiu W; Christakis I; Silva A; Bassett RL; Cao L; Meng QH; Gardner Grubbs E; Zhao H; Yao JC; Lee JE; Perrier ND
Clin Endocrinol (Oxf); 2016 Sep; 85(3):400-7. PubMed ID: 27256431
[TBL] [Abstract][Full Text] [Related]
34. Cystic Pancreatic Neuroendocrine Tumors Represent a Distinct Clinical Entity with Less Aggressive Biological Behaviors.
Cheng Y; Wu D; Wang L; Liu H; Xiong Y; Xu J; Hu S; Zhan H
J Surg Res; 2021 Apr; 260():134-140. PubMed ID: 33340866
[TBL] [Abstract][Full Text] [Related]
35. The Clinical Features and Molecular Mechanisms of ACTH-secreting Pancreatic Neuroendocrine Tumors.
Zhang C; Jin J; Xie J; Ye L; Su T; Jiang L; Zhou W; Jiang Y; Wu L; Wang T; Zhong X; Ning G; Shen B; Wang W
J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32785672
[TBL] [Abstract][Full Text] [Related]
36. Erratic oscillatory characteristics of plasma insulin concentrations in patients with insulinoma: mechanism for unpredictable hypoglycemia.
Berman N; Genter P; Chou HF; Cortez C; Bowsher R; Ipp E
J Clin Endocrinol Metab; 1997 Sep; 82(9):2899-903. PubMed ID: 9284716
[TBL] [Abstract][Full Text] [Related]
37. Forty-eight-hour fast: the diagnostic test for insulinoma.
Hirshberg B; Livi A; Bartlett DL; Libutti SK; Alexander HR; Doppman JL; Skarulis MC; Gorden P
J Clin Endocrinol Metab; 2000 Sep; 85(9):3222-6. PubMed ID: 10999812
[TBL] [Abstract][Full Text] [Related]
38. Expression of glucagon-like Peptide 1 receptor and its effects on biologic behavior in pancreatic neuroendocrine tumors.
Cases AI; Ohtsuka T; Fujino M; Ideno N; Kozono S; Zhao M; Ohuchida K; Aishima S; Nomura M; Oda Y; Mizumoto K; Tanaka M
Pancreas; 2014 Jan; 43(1):1-6. PubMed ID: 24326362
[TBL] [Abstract][Full Text] [Related]
39. Different Hormonal Expression Patterns Between Primary Pancreatic Neuroendocrine Tumors and Metastatic Sites.
Kimura H; Ohtsuka T; Fujimoto T; Date K; Matsunaga T; Cases AI; Abe A; Mizuuchi Y; Miyasaka Y; Ito T; Oda Y; Nakamura M; Tanaka M
Pancreas; 2016 Aug; 45(7):947-52. PubMed ID: 26684862
[TBL] [Abstract][Full Text] [Related]
40. Mutation and Expression of Gene YY1 in Pancreatic Neuroendocrine Tumors and Its Clinical Significance.
Song YL; Xu J; Zhao DC; Zhang TP; Jin KZ; Zhu LM; Yu S; Chen YJ
Endocr Pract; 2021 Sep; 27(9):874-880. PubMed ID: 33705973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
